Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
Key Clinical Message In cases of decompensated heart failure related to cancer therapy‐related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorable hemodynamics. Assessment of the overlap between the E‐ and A...
Main Authors: | Yusuke Nakano, Hirohiko Ando, Wataru Suzuki, Hirofumi Ohashi, Yasushi Suzuki, Hiroaki Takashima, Tetsuya Amano |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.4133 |
Similar Items
-
Cardio-toxicity among patients with sarcoma: a cardio-oncology registry
by: Sivan Shamai, et al.
Published: (2020-06-01) -
Clinical significance of spleen stiffness in patients with acute decompensated heart failure
by: Yuki Saito, et al.
Published: (2020-12-01) -
Impact of environmental factors on heart failure decompensations
by: Vanessa Escolar, et al.
Published: (2019-12-01) -
CLINICAL AND ECONOMICAL ASPECTS OF NOVEL APPROACHES TO THE TREATMENT OF CHRONIC HEART FAILURE DECOMPENSATION
by: S. K. Zyryanov, et al.
Published: (2015-03-01) -
Case Study on Cardiac Decompensation in Patients with Preeclampsia and Peripartum Cardiomyopathy
by: Evelyn Leonie Phanaka, et al.
Published: (2020-03-01)